Zignsec AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021 - Marketscreener.com
| ZIGN Stock | SEK 1.36 0.02 1.45% |
Slightly above 61% of Zignsec AB's investor base is looking to short. The analysis of current outlook of investing in Zignsec AB suggests that many traders are alarmed regarding Zignsec AB's prospects. Zignsec AB's investing sentiment can be driven by a variety of factors including economic data, Zignsec AB's earnings reports, geopolitical events, and overall market trends.
Zignsec |
Zignsec AB Publ Reports Earnings Results for the Second Quarter Ended June 30, 2021 Marketscreener.com
Read at news.google.com
 |
Zignsec AB Fundamental Analysis
We analyze Zignsec AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zignsec AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zignsec AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Revenue
Revenue Comparative Analysis
Zignsec AB is currently under evaluation in revenue category among its peers. Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Zignsec AB Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zignsec AB stock to make a market-neutral strategy. Peer analysis of Zignsec AB could also be used in its relative valuation, which is a method of valuing Zignsec AB by comparing valuation metrics with similar companies.
Peers
Zignsec AB Related Equities
| CLS-B | Clinical Laserthermia | 8.65 | ||||
| KABE-B | KABE Group | 2.43 | ||||
| MEKO | Mekonomen | 2.11 | ||||
| SPRINT | Sprint Bioscience | 1.75 | ||||
| NORVA | Norva24 Group | 1.40 | ||||
| EMBELL | Embellence Group | 1.32 | ||||
| ALBERT | EEducation Albert | 0.28 | ||||
| IAR-B | IAR Systems | 0.68 | ||||
| ANNX | Annexin Pharmaceuticals | 4.00 | ||||
| ACARIX | Acarix AS | 10.00 |
Additional Tools for Zignsec Stock Analysis
When running Zignsec AB's price analysis, check to measure Zignsec AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zignsec AB is operating at the current time. Most of Zignsec AB's value examination focuses on studying past and present price action to predict the probability of Zignsec AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zignsec AB's price. Additionally, you may evaluate how the addition of Zignsec AB to your portfolios can decrease your overall portfolio volatility.